How hepatitis C puts you at risk for diabetes

Chronic hep C is associated with an increased risk for other serious health conditions, including type 2 diabetes.

Hep C is associated with an increased risk of a long list of diseases and conditions, including diabetes.

Hepatitis C is a viral infection that causes inflammation in the liver. Although asymptomatic in most cases—meaning they do not cause symptoms—chronic hep C infections can cause serious long-term complications.

These complications can include cirrhosis, severe scarring of the liver that leaves the liver unable to function normally, as well as liver failure and liver cancer.

Even patients who are years away from these complications can experience severe health consequences as a result of a chronic hep C infection.

Hep C is associated with an increased risk of a long list of diseases and conditions, including arthritis, blood disorders, fatigue, kidney disease, and immune dysfunction.

Hep C is also associated with an increased risk of diabetes.

What is diabetes?

Diabetes is a metabolic disorder where the body is no longer able to make insulin, make adequate amounts of insulin, or is unable to use the insulin it does make.

Insulin is a hormone produced in the pancreas. It enables the body to metabolize glucose (blood sugar), one of the body’s main sources of energy.

People who are diabetic have elevated levels of glucose in the blood, which can damage the blood vessels throughout the body. This can lead to kidney disease, eye problems, nerve damage, and other complications. People with diabetes are also at a much higher risk for heart disease and stroke.

Type 2 diabetes

There are two main types of diabetes. Type 2 diabetes is the most common form:

  • Type 2 diabetes (T2D) accounts for over 90 percent of diabetes cases.
  • It occurs when the body becomes insulin resistant—unable to use insulin and/or unable to make enough insulin.
  • Risk factors for T2D include being overweight or obese, sedentary lifestyle, poor diet, older age, and a family history of the disease.

People who have hep C are more likely to have T2D as well as other metabolic disorders, including insulin resistance and metabolic syndrome.

Research suggests that there is a two-way association between the conditions—hep C infection can trigger the onset of T2D and having T2D can accelerate the damage caused by a hep C infection.

T2D can also reduce the effectiveness of hep C treatment.

There is an upside though—some research has shown that patients who have hep C and type 2 diabetes see improved blood glucose control during treatment for hep C and after successfully clearing the HCV infection.

Type 1 diabetes

The other main type of diabetes is type 1 diabetes.

  • Type1 diabetes accounts for roughly 5 percent of diabetes cases.
  • In most cases, it occurs when an autoimmune response by the body attacks the insulin-producing cells in the pancreas.
  • Once these insulin-producing cells are destroyed, the body is no longer able to make insulin.

Though it’s less common than the association with T2D—and more research is needed—hep C infections may also trigger the onset of type 1 diabetes.

Protecting your health

If you have hepatitis C, see a healthcare provider for treatment. With proper treatment, chronic hep C is highly curable.

In addition to seeking treatment for hep C, it’s also important to maintain a healthy lifestyle. Eating well, exercising regularly, maintaining a healthy weight, avoiding alcohol, and quitting smoking (if you smoke) can reduce your risk of diabetes and other conditions. Healthy habits can also help lower your risk of complications related to hep C.

Article sources open article sources

MedlinePlus. "Hepatitis C."
Mayo Clinic. "Hepatitis C."
NHS. "Hepatitis C."
Rena K. Fox and Maria A. Corcorran. "Extrahepatic Conditions Related to HCV infection." Hepatitis C Online. February 23, 2021.
UpToDate. "Patient education: Type 2 diabetes: Overview (Beyond the Basics)."
Mayo Clinic. "Diabetes."
MedlinePlus. "Diabetes Complications."
Centers for Disease Control and Prevention. "Type 2 Diabetes."
National Institute of Diabetes and Digestive and Kidney Diseases. "Risk Factors for Type 2 Diabetes."
Lucivalda Pereira Magalhaes Oliveira, Rosangela P. de Jesus, et al. "Metabolic syndrome in patients with chronic hepatitis C virus genotype 1 infection who do not have obesity or type 2 diabetes." Clinics (Sao Paulo), 2016. Vol. 67, No. 3.
Sara Salehi Hammerstad, Shira Frankel Grock, et al. "Diabetes and Hepatitis C: A Two-Way Association." Frontiers in Endocrinology, 2015. Vol. 6, No. 134.
Veronica Hackethal. "Clearing Hepatitis C Linked to Better Diabetes Control." Medscape. July 06, 2017
National Institute of Diabetes and Digestive and Kidney Diseases. "Type 1 Diabetes."
Centers for Disease Control and Prevention. "What is Type 1 Diabetes?"
Sara Salehi Hammerstad, Shira Frankel Grock, et al. "Diabetes and hepatitis C: a two-way association." Frontiers in Endocrinology. September 14, 2015.
UpToDate. "Patient education: Hepatitis C (Beyond the Basics)."
Centers for Disease Control and Prevention. "Hepatitis C Questions and Answers for the Public."

More On

Seeking hepatitis C treatment as a young patient of color

video

Seeking hepatitis C treatment as a young patient of color
“It put it in my face that people of color are mistreated when it comes to the medical industry.” - Jessica, hepatitis C patient, speaking on her expe...
How to manage hep C fatigue

article

How to manage hep C fatigue
Learn why hep C causes fatigue and what you can do about it.
My story, my diagnosis: hep C

video

My story, my diagnosis: hep C
Toni is a Chicago real estate broker and mother. After a 30 year battle, she has been cured of hepatitis C. Watch Toni's story from struggling through...
What Is Hepatitis C (HCV)?

video

What Is Hepatitis C (HCV)?
Hepatitis C (HCV) is a virus that attacks the liver, causing inflammation and other problems. In this video, liver transplant surgeon Dr. Robert Brown...
The importance of diversity in clinical trials for hepatitis C

video

The importance of diversity in clinical trials for hepatitis C
Aja McCutchen, MD, does a deep dive into why hepatitis C seems to disproportionately affect Black people. She explains the importance of diversity in ...